Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Stock-Based Compensation
$1.60M
Quarterly · Period ending: · USD
LCTX Stock-Based Compensation
Latest reported$1.60Mperiod ending
Latest reported$1.60Mperiod ending
LCTX Quarterly Stock-Based Comp ($0.00 → $1.60M)
Quarterly stock-based compensation
High-resolution chart · PNG
LCTX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,601,000 | |
| 1,172,000 | |
| 1,098,000 | |
| 1,199,000 | |
| 1,238,000 | |
| 1,217,000 | |
| 1,315,000 | |
| 1,330,000 | |
| 1,269,000 | |
| 1,163,000 | |
| 1,060,000 | |
| 1,269,000 | |
| 1,280,000 | |
| 1,031,000 | |
| 959,000 | |
| 987,000 | |
| 1,235,000 | |
| 1,106,000 | |
| 918,000 | |
| 1,143,000 | |
| 919,000 | |
| 539,000 | |
| 494,000 | |
| 501,000 | |
| 606,000 | |
| 626,000 | |
| 619,000 | |
| 759,000 | |
| 762,000 | |
| 1,440,000 | |
| 2,005,000 | |
| 1,310,000 | |
| 1,103,000 | |
| 984,000 | |
| 1,029,000 | |
| 973,000 | |
| 904,000 | |
| 1,026,000 | |
| 1,648,000 | |
| 710,000 | |
| 2,220,000 | |
| 3,373,000 | |
| 3,861,000 | |
| 3,489,000 | |
| 1,785,593 | |
| 1,914,407 | |
| 1,134,647 | |
| 1,108,632 | |
| 1,410,587 | |
| 801,554 | |
| 842,521 | |
| 1,023,559 | |
| 780,920 | |
| 570,875 | |
| 295,738 | |
| 372,264 | |
| 298,447 | |
| 316,058 | |
| 389,127 | |
| 268,313 | |
| 270,542 | |
| 289,540 | |
| 209,274 | |
| 145,305 | |
| 145,304 | |
| 138,826 | |
| 364,106 | |
| 55,433 | |
| 37,487 | |
| 31,538 | |
| 134,518 | |
| 0 | |
| 0 | |
| 39,364 | |
| 151,059 | |
| 5,723 | |
| 16,968 | |
| 50,837 | |
| 113,980 | |
| 0 | |
| 0 | |
| 15,050 | |
| 146,270 | |
| 0 | |
| 0 | |
| 15,050 | |
| 0 | |
| 0 | |
| 0 | |
| 48,276 | |
| 0 | |
| 0 | |
| 0 | |
| 38,750 | |
| 191,920 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |